Skip to main content

Year: 2025

Chicago Atlantic BDC, Inc. Reports Third Quarter 2025 Financial Results

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights and Subsequent ActivityTotal gross investment income of $15.1 million. Interest income accounted for $13.8 million, of which $1.9 million was related to one-time pre-payment premiums from early payoffs Net investment income of $9.5 million, or $0.42 per weighted average share outstanding Total investment portfolio of $311.4 million at fair value Net asset value (“NAV”) per share was $13.27 on September 30, 2025 Board of Directors declared a dividend of $0.34 per share for the quarter ending December 31, 2025...

Continue reading

Alliance Creative Group (ACGX) Releases 2025 Q3 Quarterly Financial and Disclosure Report

Strategic Expansion of AI-Driven Digital Assets and Portfolio Growth Sets the Stage for 2026 CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — via IBN — Alliance Creative Group, Inc., (http://www.ACGX.us) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Quarter Ending September  30, 2025, demonstrating steady progress in executing its multi-phase digital transformation and shared-resources business model.  Building on its Q2 foundation, the Company continued transitioning from legacy real-estate assets to a diversified portfolio of high-potential AI-enhanced digital media, marketing, and e-commerce platforms. Revenues for the Quarter ending June 30, 2025 (“Q2 2025”) were $22,734 The total assets on the Balance Sheet for the Alliance Creative Group as of 9/30/25 were $1,132,342 The total...

Continue reading

Critical One Energy Appoints Chief Geological Officer to Advance Flagship Antimony-Gold Project

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Critical One Energy Inc. (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce the appointment of Matthew Trenkler, PhD, P.Geo, as its Chief Geological Officer, effective immediately. In this role, Trenkler will lead the Company’s technical strategy, with a focus on advancing exploration at the Howells Lake Antimony-Gold Project (“Howells Lake Project”), Canada’s largest known undeveloped antimony deposit. He brings deep expertise in geological modeling, data interpretation, and integrated exploration workflows. The Howells Lake Project is located approximately 200 kilometres (km) from the Ring of Fire corridor in the Thunder Bay Mining Division of Ontario, Canada. “Matt brings the right combination of field experience, geological insight, and leadership...

Continue reading

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

Acquisition expands Day One’s portfolio with novel antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le) Emi-Le has demonstrated early anti-tumor activity in an ongoing Phase 1 study for adenoid cystic carcinoma type-1 (ACC-1), a cancer with high unmet need and a lack of therapeutic options Day One will apply existing scientific and commercial capabilities to this investigational innovative therapeutic with a clear potential registration path Company to host conference call and webcast today, November 13, 8:00 am Eastern Time BRISBANE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it has signed...

Continue reading

Day One Biopharmaceuticals to Acquire Mersana Therapeutics

Agreement with Day One Biopharmaceuticals provides for upfront consideration of $25.00 per share in cash, plus potential contingent value rights cash payments of up to an aggregate of $30.25 per share, for aggregate deal value of up to approximately $285 million Closing is expected to occur by the end of January 2026 CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it has entered into a definitive merger agreement with Day One Biopharmaceuticals (“Day One”), pursuant to which Day One would acquire Mersana, through a tender offer followed by a second step merger, for upfront consideration of $25.00 per share...

Continue reading

Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

HUNTSVILLE, Nov. 13, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug (“IND”) candidate, SER-252, for advanced Parkinson’s disease, enabled by its proprietary POZ Platform™ drug optimization technology, today announced its financial results for the third quarter ended September 30, 2025, along with key recent updates. Steve Ledger, Chief Executive Officer of Serina, stated, “The FDA’s alignment with our plan to advance SER-252 under a 505(b)(2) NDA pathway, and its recognition of the Phase 1b trial as registrational, represents a key milestone for Serina. This outcome underscores our regulatory and development strategy, positioning SER-252 for an accelerated...

Continue reading

Q1 FY2026 Operating & Financial Results

PERTH, Australia, Nov. 13, 2025 (GLOBE NEWSWIRE) — Alkane Resources Limited (“Alkane” or the “Company”) (ASX: ALK, OTC: ALKEF, TSX: ALK) is pleased to announce financial results for the first quarter ended 30 September 2025 (the “quarter” or “Q1 2026”). The Company’s condensed and consolidated interim financial result for the quarter, together with its Management’s Discussion and Analysis (“MD&A”) for the corresponding period, can be accessed under Alkane’s profile on www.sedar.com, on the Australian Securities Exchange (“ASX”) and on Alkane’s website at www.alkres.com. All currency references in this press release are in Australian dollars except as otherwise indicated. First Quarter 2026 Highlights:Strengthened Balance Sheet: Cash, bullion and listed investment balance of $191 million, after the repayment of the $45 million...

Continue reading

Aurora Mobile Limited Announces Third Quarter 2025 Unaudited Financial Results

SHENZHEN, China, Nov. 13, 2025 (GLOBE NEWSWIRE) — Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading provider of customer engagement and marketing technology services in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial HighlightsRevenues were RMB90.9 million (US$12.8 million), an increase of 15% year-over-year. Cost of revenues was RMB27.1 million (US$3.8 million), an increase of 5% year-over-year. Gross profit was RMB63.8 million (US$9.0 million), an increase of 20% year-over-year. Total operating expenses were RMB64.4 million (US$9.0 million), an increase of 13% year-over-year. Net income was RMB0.7 million (US$92 thousand), compared with a net loss of RMB2.2 million for the same quarter last year. Net loss attributable...

Continue reading

Form 8.3 – [IQE PLC – 12 11 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Kvartalsorientering for 3. kvartal 2025

Selskabsmeddelelse nr. 19 – 2025København, den 13. november 2025Kvartalsorientering for 3. kvartal 2025Selskabet offentliggør ikke finansiel information i kvartalsorienteringen.Det tidligere annoncerede køb af ejendommen beliggende Måløv Byvej 229, 2760 Måløv er gennemført den 14. august 2025.  Driften af ejendommen forløber som forventet. Selskabet har siden overtagelsen haft fokus på dialog med lejerne samt at sikre en effektiv overgang af ejendomsadministrationen.  Koncernens egenkapital pr. 30. september 2025 estimeres til DKK 9,2 mio., svarende til en indre værdi pr. aktie på DKK 3,7.  NTR Holding-koncernen forventer i 2025 uændret en omsætning i niveauet DKK 4 mio. og et resultat før kurs- og værdireguleringer i niveauet DKK 0 mio.  Bestyrelsen vil søge NTR Holding A/S afnoteret inden selskabets ordinære generalforsamling i 2026...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.